Is the Search for Enough Moderate-Severe Ischemia Nearly Over?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. Assessment of the routine reporting of very low-dose exercise-first myocardial perfusion SPECT from a large-scale real-world cohort and correlation with the subsequent reporting of coronary stenosis at angiography.European journal of nuclear medicine and molecular imaging · 2022
   Article
2. Epidemiology and pathophysiologic insights of coronary atherosclerosis relevant for contemporary non-invasive imaging.Cardiovascular diagnosis and therapy · 2020
   Review
3. Coronary Disease Surveillance in the Community: Angiography and Revascularization.Journal of the American Heart Association · 2020
   Article

Corrections and comments

• Comment on
  Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial.2019

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as